Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, November 14, 2024
Flashpoint Therapeutics announced a significant expansion of its therapeutic pipeline through strategic acquisitions and a new partnership valued at $50M with The King Abdullah International Medical Research Center (KAIMRC) in Saudi Arabia.
read more
Thursday, November 18, 2021
Gamma Biosciences, a global life sciences company serving the advanced therapy market, today announced that portfolio company BioMagnetic Solutions (BMS) has signed a lease with GLP Development to build a cGMP-grade production facility in Innovation ...
read more
Thursday, February 03, 2022
CordenPharma has announced the completion of the acquisition of three manufacturing facilities from Vifor Pharma, to be ultimately renamed Corden Pharma Fribourg S.A. (including its Ettingen branch) in Switzerland, and Corden Pharma Lisbon S.A. in ...
read more
Thermo Fisher Scientific opened its new business center and biorepository in Frederick, Md. with a ribbon-cutting ceremony.
read more
PAREXEL announced the CEO Roundtable on Cancer has again named PAREXEL a CEO Cancer Gold Standard employer.
read more
Wednesday, February 19, 2020
Dr. Reddy’s Laboratories has entered into a definitive agreement with Wockhardt Limited to acquire select divisions of its branded generics business.
read more
Tuesday, December 29, 2020
Quantum Genomics has signed a strategic contract with Delpharm for the manufacture of the next clinical batches of firibastat tablets on an industrial scale and the establishment of production lines for future commercial batches.
read more
Wednesday, September 16, 2015
NVS Influenza Vaccines, now owned and operated by the CSL Limited, announced that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the US Food and Drug Administration (FDA) voted to recommend licensure of a candidate ...
read more
Friday, February 04, 2022
Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer® and pre|CISION™ platforms, announces that the first-in-human Phase I trial (ALS-6000-101) of AVA6000 Pro-...
read more
Tuesday, November 19, 2024
Safecor Health has acquired the U.S. unit-dose packaging business of Viatris Inc. The business was formerly known as Unit Dose Laboratories, or UDL.
read more
INC Research announced the launch of Psychiatry Catalyst Site Network as part of its Catalyst program introduced in 2016 to collaborate with clinical research sites worldwide.
read more
Monday, November 26, 2018
Ligand has entered into a worldwide OmniAb partnership with iMetabolic Biopharma Corporation (iMBP), an early stage biopharma company located in Tempe, AZ.
read more
Sekisui Diagnostics Enzyme business announces the completion of a new BioProcess Innovation Centre at the site in Maidstone, Kent by the end of 2019, following a $1.9 million investment.
read more
Emulate, Inc. has announced a strategic collaboration with Laboratory Corporation of America® Holdings (LabCorp®) that seeks to integrate Emulate’s Organs-on-Chips technology into preclinical drug evaluation and testing services.
read more
Simulations Plus announced a funded research collaboration with Lonza Group AG and the FDA to develop and validate a mechanistic, predictive framework for assessing the in vivo performance of amorphous solid dispersion (ASD) drug products.
read more